Back to company

Save Stemcell Center ApS: Financial statements 2024

CVR: 39936119

Save Stemcell Center ApS (CVR 39936119) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -128,303 and a net result of DKK -158,178 compared with DKK 73,835 the year before. Equity amounted to DKK -740,885. The company had 1 employee in the financial year.

Gross Profit
-128,303 kr.
Profit/Loss
-158,178 kr.
Equity
-740,885 kr.
Total Assets
15,235 kr.
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024--128 t.-158 t.-741 t.1
2023-335 t.74 t.-583 t.0
2022-85 t.-139 t.-657 t.0
2021-542 t.-429 t.-517 t.1
2020-1.1 mio.-205 t.-89 t.1

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Save Stemcell Center ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2024

Save Stemcell Center ApS: The 2023 annual report is outJul 4, 2024

Save Stemcell Center ApS has published its annual report for 2023. Gross profit came to DKK 335,479, and the net result was DKK 73,835.

About Save Stemcell Center ApS

Save Stemcell Center ApS is a Danish company of the type Anpartsselskab based in Slagelse, founded in 2018. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Louise Camilla Zielinski. The company is owned by STORKEREDEN ApS. The company has 0 employees. In 2025, the company reported a gross profit of DKK -25,469 and a net result of DKK -25,544 compared with DKK -158,178 the year before. Equity amounted to DKK -766,429.

Other financial years